{"id":"W2025533780","doi":"10.1111/ejh.12491","title":"Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation","year":2014,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharmaceuticals Corporation; Celgene","keywords":"Medicine; Refractory (planetary science); Internal medicine; Multiple myeloma; Gastroenterology; Clinical endpoint; Adverse effect; Chromosomal translocation; Dexamethasone; Clinical trial; Surgery; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001295313,0.001192065,0.001605735,0.0002972837,0.000353488,0.0007243348,0.000626834,0.0009540675,0.002277236],"category_scores_gemma":[0.0006707838,0.0005036209,0.0007605655,0.0003167723,0.0004717912,0.000614207,0.0003083275,0.001736936,0.0005337014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006913699,"about_ca_system_score_gemma":0.001232297,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007703321,"about_ca_topic_score_gemma":0.002010578,"domain_scores_codex":[0.999723,0.0001161456,0.00001482524,0.00005361572,0.00002726371,0.00006518026],"domain_scores_gemma":[0.9996213,0.00005199981,0.00008606701,0.00003078467,0.00002938278,0.0001805032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6592039,0.09328994,0.0255729,0.0008271332,0.001687116,0.0006694606,0.0004047941,0.004315219,0.09441191,0.0003909184,0.005813025,0.1134137],"study_design_scores_gemma":[0.5823913,0.3795447,0.02557104,0.00003250776,0.0003939797,0.0006373916,0.00006469233,0.002036968,0.005643225,0.0001530018,0.00350299,0.00002827096],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955428,0.001009934,0.0003003777,0.0002681296,0.00005837165,0.001379721,0.0006025274,0.00004744966,0.0007906316],"genre_scores_gemma":[0.9930171,0.0008780681,0.0009713796,0.0005153701,0.00009688137,0.001424309,0.001709095,0.00001874541,0.00136908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002277236,"threshold_uncertainty_score":0.00761807,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02976072152649583,"score_gpt":0.311031236984917,"score_spread":0.2812705154584212,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}